We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Welcome to another episode of the Industry Voice Podcast series, in which we delve into the world of biopharmaceutical innovation and global collaborations. This time we sit down with Dr. Luo Shan, the Founder and Chairman of JS Bio, a pioneering cell culture media supplier with a global footprint across the United States and China. Join us for this conversation as we unravel the intersection of innovations and differences when doing biopharmaceutical business internationally.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
